aspira-pathlab-diagnostics-ltd
Home
Aspira Pathlab & Diagnostics Ltd
null Share Price
BSE:
NSE:
null Share Price
BSE:
NSE:
Healthcare
Small Cap
₹-
0 (0%)
Market Cap
₹69.39 Cr
Aspira Pathlab & Diagnostics Ltd Performance
▲
▲
▲
▲
Aspira Pathlab & Diagnostics Ltd Fundamentals
Aspira Pathlab & Diagnostics Ltd Delivery and Volume
About Aspira Pathlab & Diagnostics Ltd
Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973. ASDL is a leading pathology specialist, with Pan-India presence. It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses. The Company, with a wider presence in
| Name | Designation |
|---|---|
| Pankaj Jashwant Shah | Managing Director & CEO |
| Arvind Karsandas Bhanushali | Non Executive Director |
| Mangala Radha Krishnan Prabhu | Independent Director |
| Haseeb Drabu | Chairman & Independent Directo |
| Nikunj Mange | Non Executive Director |
| Subhash Raghunath Salunke | Independent Director |
| A C Mahajan | Independent Director |
| Manas Mengar | Independent Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Aspira Pathlab & Diagnostics Ltd FAQs
How do I Buy Aspira Pathlab & Diagnostics Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Aspira Pathlab & Diagnostics Ltd shares in BlinkX.
What is the Share Price of Aspira Pathlab & Diagnostics Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Aspira Pathlab & Diagnostics Ltd's share price is ₹67.41 as of 2024-12-14.
What is the PE ratio of Aspira Pathlab & Diagnostics Ltd?
Aspira Pathlab & Diagnostics Ltd's P/E ratio is - times as of 2024-12-14.
What is the PB ratio of Aspira Pathlab & Diagnostics Ltd?
Aspira Pathlab & Diagnostics Ltd's most recent financial reports indicate a price-to-book ratio of 6.24, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Aspira Pathlab & Diagnostics Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Aspira Pathlab & Diagnostics Ltd's market capitalization is ₹69.39 Cr as on 2024-12-14.
What is the ROE of Aspira Pathlab & Diagnostics Ltd?
The current financial records of Aspira Pathlab & Diagnostics Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Aspira Pathlab & Diagnostics Ltd?
According to Aspira Pathlab & Diagnostics Ltd's most recent financial filings, the company has a total asset value of ₹4.36, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Aspira Pathlab & Diagnostics Ltd?
The 52-week high/low price of a Aspira Pathlab & Diagnostics Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Aspira Pathlab & Diagnostics Ltd's 52-week high and low as of 2024-12-14 are ₹67.41 and ₹67.41, respectively.
